Da Silva G J, Van Der Reijden T, Domingues S, Mendonça N, Petersen K, Dijkshoorn L
Center of Pharmaceutical Studies, Faculty of Pharmacy,University of Coimbra,Coimbra,Portugal.
Department of Infectious Diseases,Leiden University Medical Centre,Leiden,The Netherlands.
Epidemiol Infect. 2014 Jul;142(7):1554-8. doi: 10.1017/S0950268813002288. Epub 2013 Sep 30.
Twelve non-replicate Acinetobacter baumannii isolates from five European hospitals, Kuwait, and the US military healthcare system collected between 1980 and 2005 revealed a new clone, CC32. These included representative isolates of outbreaks/cross-infections. Antimicrobial susceptibility and carbapenem-resistant genetic traits varied. The widespread occurrence, the association with an outbreak and the carbapenem resistance indicate that CC32 has epidemic potential.
1980年至2005年间从欧洲五家医院、科威特以及美国军事医疗系统收集的12株非重复鲍曼不动杆菌分离株显示出一个新的克隆群CC32。这些分离株包括暴发/交叉感染的代表性菌株。抗菌药物敏感性和耐碳青霉烯类遗传特征各不相同。其广泛存在、与暴发的关联以及对碳青霉烯类的耐药性表明CC32具有流行潜力。